GGrantIndex
Sort

40,608 grants matching prostate cancer

Elucidating the Role of Trop2 in Prostate Cancer

$374,962
Tanya I Stoyanova · Stanford University · R37 · FY2020 · CA

Targeted tumoricidal bacteria

$374,950
Ming Zhao · Anticancer, Inc. · R44 · FY2010 · CA

ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER

$374,908
University Of Maryland Baltimore · R01 · FY2003 · CA

Pooling of Prospective Studies of Diet and Cancer

$374,862
Stephanie A Smith-Warner · Harvard School Of Public Health · P01 · FY2009 · CA

INTERACTIVE IMAGE GUIDED CLOSED LOOP THERMAL THERAPY

$374,858
Biotex, Inc. · R44 · FY2000 · CA

Phytotherapy for Benign Prostatic Hyperplasia

$374,812
Kaiser Foundation Research Institute · U01 · FY2004 · DK

Understanding Resistance to Next Generation Antiandrogens

$374,735
Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA

Elucidating a novel molecular biomarker for castration-resistant prostate cancer

$374,728
Nima Sharifi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · CA

Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence

$374,728
Lewis A Chodosh · University Of Pennsylvania · R01 · FY2022 · CA

Polypeptide Vaccine In IL-2 Liposomes For Prostate Ca

$374,727
New York University School Of Medicine · R01 · FY2002 · CA

Vitamin D Analogs for Chemoprevention of Prostate CAncer

$374,697
Barbara A Foster · Roswell Park Cancer Institute Corp · R01 · FY2011 · CA

Vitamin D Analogs for Chemoprevention of Prostate CAncer

$374,697
Barbara A Foster · Roswell Park Cancer Institute Corp · R01 · FY2012 · CA

Vitamin D in Prostate Cancer: Tumor Vasculature Effects

$374,690
Donald L Trump · Roswell Park Cancer Institute Corp · R01 · FY2006 · CA

Heparan Sulfate in Prostate Cancer

$374,688
Lianchun Wang · University Of South Florida · U01 · FY2023 · CA

Distributed knowledge-based platform for radiotherapy plan quality control

$374,613
Kevin Lawrence Moore · University Of California, San Diego · R01 · FY2021 · HS

Distributed knowledge-based platform for radiotherapy plan quality control

$374,612
Kevin Lawrence Moore · University Of California, San Diego · R01 · FY2020 · HS

Distributed knowledge-based platform for radiotherapy plan quality control

$374,612
Kevin Lawrence Moore · University Of California, San Diego · R01 · FY2019 · HS

TENASCIN STRUCTURE AND ROLE IN NEOPLASIA

$374,609
La Jolla Inst For Molecular Medicine · R01 · FY2000 · CA

Cancer stem cells and human liver cancer

$374,580
Snorri Thorgeirsson · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Tumor Cell Biology Training Program

$374,579
Gay Miriam Crooks · University Of California Los Angeles · T32 · FY2014 · CA

Immunogenomic determinants of response and resistance to neoadjuvant anti-PD-1 in resectable NSCLC

$374,578
Kellie Nicole Smith · Johns Hopkins University · R37 · FY2025 · CA

Mechanisms by which histone methyltransferases regulate nuclear receptor activity and response to therapy in hormone-driven tumors.

$374,578
Eneda Toska · Johns Hopkins University · R01 · FY2023 · CA

Genetic and genomic determinants of homologous recombination repair deficiency as treatment selection markers for lethal prostate cancer

$374,578
Jun Luo · Johns Hopkins University · R01 · FY2020 · CA

Mechanisms by which histone methyltransferases regulate nuclear receptor activity and response to therapy in hormone-driven tumors.

$374,578
Eneda Toska · Johns Hopkins University · R01 · FY2025 · CA

Genetic and genomic determinants of homologous recombination repair deficiency as treatment selection markers for lethal prostate cancer

$374,578
Jun Luo · Johns Hopkins University · R01 · FY2021 · CA